Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweet Chemistry is a science-driven cosmeceutical company that leverages advanced regenerative medicine research to develop high-performance skincare. The company's core technology centers on a proprietary Matrikine Peptide Complex, originally derived from bone-tissue regeneration studies, designed to stimulate the skin's natural repair mechanisms. By utilizing pharmaceutical-grade ingredients and a "less is more" formulation philosophy, Sweet Chemistry aims to optimize skin health and reverse signs of aging. Their product line currently includes specialized creams and oil-serums that target the extracellular matrix to improve elasticity and structural integrity. Founded by industry veteran Alec Batis, the brand bridges the gap between clinical biotechnology and luxury consumer skincare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweet Chemistry.